North America Contrast Agents Market Outlook to 2033: Computed Tomography (CT) Contrast Agents, Ultrasound Contrast Agents (Microbubbles) and Others

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$5995
Buy Report

Published: September 04, 2025 Report Code: GDME20519CRDB-ST

Select Item

GlobalData’s “North America Contrast Agents Market Outlook to 2033” is a comprehensive databook report, covering key market data on the North America Contrast Agents market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Computed Tomography (CT) Contrast Agents, Magnetic Resonance Imaging (MRI) Contrast Agents and Ultrasound Contrast Agents (Microbubbles)

The North America Contrast Agents Market report provides key information and data on –
• Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2018 to 2033.
• 2023 company share data for Contrast Agents Market.
• Global corporate-level profiles of key companies operating within the North America Contrast Agents Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

North America Contrast Agents is segmented as follows – _x000D_

• Computed Tomography (CT) Contrast Agents_x000D_

• Magnetic Resonance Imaging (MRI) Contrast Agents_x000D_

• Ultrasound Contrast Agents (Microbubbles)

Reasons to Buy

The North America Contrast Agents Market report helps you to develop –

• Business strategies by identifying the key market segments poised for strong growth in the future.

• Market-entry and market expansion strategies.

• Design competition strategies by identifying who-stands-where in the market.

• Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

Bracco Imaging SpA_x000D_
GE HealthCare Technologies Inc_x000D_
Bayer AG_x000D_
Lantheus Medical Imaging Inc_x000D_
Guerbet SA

Table of Contents

|1 Table of Contents 3

|1.1 List of Tables 5

|1.2 List of Figures 5

2 Introduction 7

2.1 What Is This Report About? 7

2.2 Contrast Agents Market Segmentation 7

2.3 Definitions of Markets Covered in the Report 8

3 Contrast Agents Market, North America 10

3.1 Contrast Agents Market, North America, Revenue ($m), 2018-2033 10

3.2 Contrast Agents Market, North America, Revenue ($m), 2018-2033 12

3.3 Contrast Agents Market, North America, Volume (Units), 2018-2033 15

3.4 Contrast Agents Market, North America, Volume (Units), 2018-2033 17

3.5 Contrast Agents Market, North America, Company Share by Revenue ($m), 2024 20

4 Contrast Agents Market, Mexico 22

4.1 Contrast Agents Market, Mexico, Revenue ($m), 2018-2033 22

4.1.1 Computed Tomography (CT) Contrast Agents Market, Mexico, Revenue ($m), by Segment, 2018-2033 24

4.1.2 Magnetic Resonance Imaging (MRI) Contrast Agents Market, Mexico, Revenue ($m), by Segment, 2018-2033 26

4.2 Contrast Agents Market, Mexico, Volume (Units), 2018-2033 28

4.2.1 Computed Tomography (CT) Contrast Agents Market, Mexico, Volume (Units), by Segment, 2018-2033 30

4.2.2 Magnetic Resonance Imaging (MRI) Contrast Agents Market, Mexico, Volume (Units), by Segment, 2018-2033 33

4.3 Contrast Agents Market, Mexico, Average Price ($) , 2018-2033 35

4.4 Contrast Agents Market, Mexico, Company Share by Revenue ($m), 2024 36

5 Contrast Agents Market, Canada 38

5.1 Contrast Agents Market, Canada, Revenue ($m), 2018-2033 38

5.1.1 Computed Tomography (CT) Contrast Agents Market, Canada, Revenue ($m), by Segment, 2018-2033 40

5.1.2 Magnetic Resonance Imaging (MRI) Contrast Agents Market, Canada, Revenue ($m), by Segment, 2018-2033 42

5.2 Contrast Agents Market, Canada, Volume (Units), 2018-2033 44

5.2.1 Computed Tomography (CT) Contrast Agents Market, Canada, Volume (Units), by Segment, 2018-2033 46

5.2.2 Magnetic Resonance Imaging (MRI) Contrast Agents Market, Canada, Volume (Units), by Segment, 2018-2033 49

5.3 Contrast Agents Market, Canada, Average Price ($) , 2018-2033 51

5.4 Contrast Agents Market, Canada, Company Share by Revenue ($m), 2024 52

6 Contrast Agents Market, United States 54

6.1 Contrast Agents Market, United States, Revenue ($m), 2018-2033 54

6.1.1 Computed Tomography (CT) Contrast Agents Market, United States, Revenue ($m), by Segment, 2018-2033 56

6.1.2 Magnetic Resonance Imaging (MRI) Contrast Agents Market, United States, Revenue ($m), by Segment, 2018-2033 58

6.2 Contrast Agents Market, United States, Volume (Units), 2018-2033 60

6.2.1 Computed Tomography (CT) Contrast Agents Market, United States, Volume (Units), by Segment, 2018-2033 62

6.2.2 Magnetic Resonance Imaging (MRI) Contrast Agents Market, United States, Volume (Units), by Segment, 2018-2033 65

6.3 Contrast Agents Market, United States, Average Price ($) , 2018-2033 67

6.4 Contrast Agents Market, United States, Company Share by Revenue ($m), 2024 68

7 Overview of Key Companies in North America Contrast Agents Market 70

7.1 Bracco Imaging SpA 70

7.1.1 Company Overview 70

7.2 GE HealthCare Technologies Inc 70

7.2.1 Company Overview 70

7.3 Bayer AG 70

7.3.1 Company Overview 70

7.4 Lantheus Medical Imaging Inc 70

7.4.1 Company Overview 70

7.5 Guerbet SA 71

7.5.1 Company Overview 71

8 Contrast Agents Market Pipeline Products 72

9 Recent Developments 80

9.1 Corporate Communications 80

9.1.1 May 12, 2025: Voyageur Pharmaceuticals Announces Appointment of Ethan Mohan as Executive Vice President 80

9.2 Financial Announcements 80

9.2.1 Nov 07, 2024: Ligand Reports Third Quarter 2024 Financial Results and Raises 2024 Guidance 80

9.2.2 Aug 08, 2024: Cellectar Biosciences to Announce First Quarter Financial Results and Host a Conference Call on Tuesday, August 13, 2024 83

9.3 Government and Public Interest 83

9.3.1 Aug 20, 2024: Ligand to Present at H.C. Wainwright 26th Annual Global Investment Conference 83

9.4 Other Significant Developments 83

9.4.1 Feb 03, 2025: GE HealthCare to invest $138m in Irish contrast media facility 83

9.5 Product News 84

9.5.1 Jul 15, 2024: Vanderbilt Scientists Develop New Tool That Could Lead to Noninvasive “liquid biopsies” 84

9.6 Strategy And Business Planning 85

9.6.1 Jun 02, 2025: ASP Isotopes and Isotopia Announce Supply Agreement for Gadolinium-160 to Accelerate Terbium-161 Production for Advanced Cancer Therapies 85

10 Appendix 86

10.1 Research Methodology 87

10.1.1 Coverage 87

10.1.2 Secondary Research 87

10.1.3 Primary Research 87

10.1.4 Market Modeling and Forecasting 88

10.1.5 Company Share Analysis 90

10.1.6 Benchmarking 90

10.2 GlobalData Consulting 90

10.3 Contact Us 91

10.4 Disclaimer 91

Table

Table 1: Contrast Agents Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2018-2033 11

Table 2: Contrast Agents Market, North America, Revenue ($m), USD Constant, 2018-2033 14

Table 3: Contrast Agents Market, North America, Volume (Units), 2018-2033 16

Table 4: Contrast Agents Market, North America, Volume (Units), 2018-2033 19

Table 5: Contrast Agents Market, North America, Company Share by Revenue ($m), 2024 21

Table 6: Contrast Agents Market, Mexico, Revenue ($m), USD Constant, 2018-2033 23

Table 7: Computed Tomography (CT) Contrast Agents Market, Mexico, Revenue ($m), USD Constant, 2018-2033 25

Table 8: Magnetic Resonance Imaging (MRI) Contrast Agents Market, Mexico, Revenue ($m), USD Constant, 2018-2033 27

Table 9: Contrast Agents Market, Mexico, Volume (Units), 2018-2033 29

Table 10: Computed Tomography (CT) Contrast Agents Market, Mexico, Volume (Units), 2018-2033 31

Table 11: Magnetic Resonance Imaging (MRI) Contrast Agents Market, Mexico, Volume (Units), 2018-2033 34

Table 12: Contrast Agents Market, Mexico, Average Price ($), 2018-2033 35

Table 13: Contrast Agents Market, Mexico, Company Share by Revenue ($m), 2024 37

Table 14: Contrast Agents Market, Canada, Revenue ($m), USD Constant, 2018-2033 39

Table 15: Computed Tomography (CT) Contrast Agents Market, Canada, Revenue ($m), USD Constant, 2018-2033 41

Table 16: Magnetic Resonance Imaging (MRI) Contrast Agents Market, Canada, Revenue ($m), USD Constant, 2018-2033 43

Table 17: Contrast Agents Market, Canada, Volume (Units), 2018-2033 45

Table 18: Computed Tomography (CT) Contrast Agents Market, Canada, Volume (Units), 2018-2033 47

Table 19: Magnetic Resonance Imaging (MRI) Contrast Agents Market, Canada, Volume (Units), 2018-2033 50

Table 20: Contrast Agents Market, Canada, Average Price ($), 2018-2033 51

Table 21: Contrast Agents Market, Canada, Company Share by Revenue ($m), 2024 53

Table 22: Contrast Agents Market, United States, Revenue ($m), USD Constant, 2018-2033 55

Table 23: Computed Tomography (CT) Contrast Agents Market, United States, Revenue ($m), USD Constant, 2018-2033 57

Table 24: Magnetic Resonance Imaging (MRI) Contrast Agents Market, United States, Revenue ($m), USD Constant, 2018-2033 59

Table 25: Contrast Agents Market, United States, Volume (Units), 2018-2033 61

Table 26: Computed Tomography (CT) Contrast Agents Market, United States, Volume (Units), 2018-2033 63

Table 27: Magnetic Resonance Imaging (MRI) Contrast Agents Market, United States, Volume (Units), 2018-2033 66

Table 28: Contrast Agents Market, United States, Average Price ($), 2018-2033 67

Table 29: Contrast Agents Market, United States, Company Share by Revenue ($m), 2024 69

Table 30: Contrast Agents Market Pipeline Products 72

Table 31: Total Number of Primary Research Participants, Diagnostic Imaging Market, by Country 88

Figures

Figure 1: Contrast Agents Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2018-2033 10

Figure 2: Contrast Agents Market, North America, Revenue ($m), USD Constant, 2018-2033 12

Figure 3: Contrast Agents Market, North America, Volume (Units), 2018-2033 15

Figure 4: Contrast Agents Market, North America, Volume (Units), 2018-2033 17

Figure 5: Contrast Agents Market, North America, Company Share (%), 2024 20

Figure 6: Contrast Agents Market, Mexico, Revenue ($m), USD Constant, 2018-2033 22

Figure 7: Computed Tomography (CT) Contrast Agents Market, Mexico, Revenue ($m), USD Constant, 2018-2033 24

Figure 8: Magnetic Resonance Imaging (MRI) Contrast Agents Market, Mexico, Revenue ($m), USD Constant, 2018-2033 26

Figure 9: Contrast Agents Market, Mexico, Volume (Units), 2018-2033 28

Figure 10: Computed Tomography (CT) Contrast Agents Market, Mexico, Volume (Units), 2018-2033 30

Figure 11: Magnetic Resonance Imaging (MRI) Contrast Agents Market, Mexico, Volume (Units), 2018-2033 33

Figure 12: Contrast Agents Market, Mexico, Company Share (%), 2024 36

Figure 13: Contrast Agents Market, Canada, Revenue ($m), USD Constant, 2018-2033 38

Figure 14: Computed Tomography (CT) Contrast Agents Market, Canada, Revenue ($m), USD Constant, 2018-2033 40

Figure 15: Magnetic Resonance Imaging (MRI) Contrast Agents Market, Canada, Revenue ($m), USD Constant, 2018-2033 42

Figure 16: Contrast Agents Market, Canada, Volume (Units), 2018-2033 44

Figure 17: Computed Tomography (CT) Contrast Agents Market, Canada, Volume (Units), 2018-2033 46

Figure 18: Magnetic Resonance Imaging (MRI) Contrast Agents Market, Canada, Volume (Units), 2018-2033 49

Figure 19: Contrast Agents Market, Canada, Company Share (%), 2024 52

Figure 20: Contrast Agents Market, United States, Revenue ($m), USD Constant, 2018-2033 54

Figure 21: Computed Tomography (CT) Contrast Agents Market, United States, Revenue ($m), USD Constant, 2018-2033 56

Figure 22: Magnetic Resonance Imaging (MRI) Contrast Agents Market, United States, Revenue ($m), USD Constant, 2018-2033 58

Figure 23: Contrast Agents Market, United States, Volume (Units), 2018-2033 60

Figure 24: Computed Tomography (CT) Contrast Agents Market, United States, Volume (Units), 2018-2033 62

Figure 25: Magnetic Resonance Imaging (MRI) Contrast Agents Market, United States, Volume (Units), 2018-2033 65

Figure 26: Contrast Agents Market, United States, Company Share (%), 2024 68

North America Contrast Agents Market Outlook to 2033: Computed Tomography (CT) Contrast Agents, Ultrasound Contrast Agents (Microbubbles) and Others standard reports
Currency USD
$5,995

Can be used by individual purchaser only

Most Popular
$11,990

Can be shared by unlimited users within one corporate location e.g. a regional office

$17,985

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Add to Basket

Undecided about purchasing this report?

Enquire Before Buying

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

See what our customers are saying
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

 Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

 Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

 Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

 Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

 Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

 Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

 Senior Account Manager, TSYS

Related reports

View more Diagnostic Imaging reports
Medical Devices
New
Global M&A Deals in H1 2026 - Top Themes by…
$495 | August 2026
Medical Devices
New
Medical Devices M&A Deals H1 2026 - Top Themes: Strategic…
$495 | July 2026
Medical Devices
New
AI-designed Materials: Market Trends and Innovations
$995 | July 2026
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at North America Contrast Agents Market Outlook to 2033: Computed Tomography (CT) Contrast Agents, Ultrasound Contrast Agents (Microbubbles) and Others in real time.

  • Access a live North America Contrast Agents Market Outlook to 2033: Computed Tomography (CT) Contrast Agents, Ultrasound Contrast Agents (Microbubbles) and Others dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.
Tell me more